X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (120) 120
human necessities (113) 113
hygiene (113) 113
medical or veterinary science (113) 113
preparations for medical, dental, or toilet purposes (113) 113
specific therapeutic activity of chemical compounds ormedicinal preparations (96) 96
female (80) 80
middle aged (68) 68
male (66) 66
adult (64) 64
index medicus (58) 58
aged (53) 53
dermatology (50) 50
chemistry (43) 43
metallurgy (43) 43
oncology (43) 43
organic chemistry (43) 43
psoriasis (43) 43
treatment outcome (31) 31
aged, 80 and over (30) 30
psoriasis - drug therapy (30) 30
drug therapy (27) 27
heterocyclic compounds (27) 27
double-blind method (25) 25
therapy (19) 19
adolescent (18) 18
care and treatment (18) 18
peptides (18) 18
severity of illness index (18) 18
drug administration schedule (17) 17
efficacy (17) 17
gastroenterology and hepatology (17) 17
abridged index medicus (16) 16
celiac disease (16) 16
medical colleges (16) 16
double-blind (15) 15
research (15) 15
analysis (14) 14
cancer (14) 14
everolimus (14) 14
medicine & public health (14) 14
psoriasis - therapy (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
breast neoplasms - drug therapy (13) 13
clinical trials (13) 13
sirolimus - analogs & derivatives (13) 13
immunosuppressive agents - therapeutic use (12) 12
administration, oral (11) 11
animals (11) 11
breast cancer (11) 11
breast neoplasms - pathology (11) 11
child (11) 11
diagnosis (11) 11
disease-free survival (11) 11
medicine, general & internal (11) 11
skin (11) 11
children (10) 10
dermatologic agents (10) 10
dermatologic agents - therapeutic use (10) 10
etanercept (10) 10
formulae, receipts, prescriptions (10) 10
methotrexate (10) 10
neoplasm metastasis (10) 10
pharmacology & pharmacy (10) 10
tumors (10) 10
administration, topical (9) 9
chemotherapy (9) 9
dermatologic agents - adverse effects (9) 9
disease (9) 9
diseases (9) 9
dose-response relationship, drug (9) 9
gastroenterology & hepatology (9) 9
gluten (9) 9
internal medicine (9) 9
neoplasms - drug therapy (9) 9
quality-of-life (9) 9
safety (9) 9
sirolimus - therapeutic use (9) 9
trial (9) 9
administration, cutaneous (8) 8
antineoplastic agents - therapeutic use (8) 8
breast-cancer (8) 8
dermatologic agents - administration & dosage (8) 8
dermatology & venereal diseases (8) 8
follow-up studies (8) 8
gastroenterology (8) 8
maximum tolerated dose (8) 8
medical research (8) 8
paclitaxel (8) 8
patients (8) 8
skin diseases (8) 8
time factors (8) 8
usage (8) 8
young adult (8) 8
adalimumab (7) 7
article (7) 7
chronic plaque psoriasis (7) 7
cyclosporine (7) 7
disease progression (7) 7
immunosuppressive agents - adverse effects (7) 7
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (320) 320
French (32) 32
German (13) 13
Portuguese (7) 7
Chinese (6) 6
Spanish (6) 6
Norwegian (4) 4
Korean (3) 3
Danish (2) 2
Slovenian (2) 2
Croatian (1) 1
Greek (1) 1
Hungarian (1) 1
Japanese (1) 1
Lithuanian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9861, pp. 125 - 132
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9808, pp. 2005 - 2012
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9637, pp. 449 - 456
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2011, Volume 29, Issue 15, pp. 1997 - 2003
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 5, pp. 439 - 448
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 6, pp. 520 - 529
Resistance to hormone therapy through activation of cellular pathways involving mTOR can develop in postmenopausal hormone-receptor–positive breast cancer.... 
TRIAL | WOMEN | MEDICINE, GENERAL & INTERNAL | EFFICACY | TAMOXIFEN | PHASE-III | LETROZOLE | SUPERIOR | AROMATASE INHIBITORS | FIRST-LINE THERAPY | ANASTROZOLE | Recurrence | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Bone Neoplasms - secondary | TOR Serine-Threonine Kinases - antagonists & inhibitors | Aromatase Inhibitors - adverse effects | Breast Neoplasms - chemistry | Aged, 80 and over | Postmenopause | Adult | Female | Aromatase Inhibitors - therapeutic use | Everolimus | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Kaplan-Meier Estimate | Receptor, Epidermal Growth Factor - analysis | Breast Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Stomatitis - chemically induced | Aged | Androstadienes - therapeutic use | Androstadienes - adverse effects | Drugs | Care and treatment | Usage | Hormone therapy | Patient outcomes | Drug utilization | Breast cancer | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | TOR protein | Anastrozole | Endocrine therapy | Fatigue | Intracellular signalling | Rapamycin | Tamoxifen | Cancer therapies | Survival | Post-menopause | Fulvestrant | Signal transduction | Stomatitis | Hyperglycemia | Chemotherapy | Pneumonitis | Dyspnea | Aromatase | Antitumor activity | Respiration
Journal Article